JB Chemicals & Pharmaceuticals Limited has scheduled a Board Meeting on May 11, 2026. The board will consider audited standalone and consolidated financial results for the year ended March 2026 and recommend a final dividend. The trading window remains closed until May 13, 2026.
JB Chemicals & Pharmaceuticals Limited has scheduled a board meeting for May 11, 2026. The board will consider audited standalone and consolidated financial results for the year ended March 31, 2026, and recommend a final dividend. Trading window closure began on April 1, 2026.
J. B. Chemicals & Pharmaceuticals Ltd has scheduled a Board Meeting on May 11, 2026. The board will consider standalone and consolidated audited financial results for FY 2025-26 and recommend a final dividend.